AAOS 2014:RA不增加同期双侧TKA围手术期并发症发生

2014-03-11 佚名 丁香园

严重的类风湿性关节炎(RA)可以引起成人残疾,造成行动和功能障碍。而且相对于骨性关节炎(OA)患者,RA患者双侧膝关节屈曲挛缩、多平面多关节畸形以及较差的健康状况都会给外科医生增加手术难度。williamhill asia 比较同期双侧膝关节置换术(BTKA)的RA和OA患者的30天死亡率、住院并发症率和发病率、死亡率的风险。 方法:分析该医院1998~2011年间行BTKA的240例RA患者和3680例OA患者资料。统计患

背景:

严重的类风湿性关节炎(RA)可以引起成人残疾,造成行动和功能障碍。而且相对于骨性关节炎(OA)患者,RA患者双侧膝关节屈曲挛缩、多平面多关节畸形以及较差的健康状况都会给外科医生增加手术难度。williamhill asia 比较同期双侧膝关节置换术(BTKA)的RA和OA患者的30天死亡率、住院并发症率和发病率、死亡率的风险。

方法:

分析该医院1998~2011年间行BTKA的240例RA患者和3680例OA患者资料。统计患者的人口学资料,包括Deyo合并症指数和30天死亡率。总的来说,RA患者比OA患者更年轻(60.9±11.8和65.4±8.4年;p<0.001),但疾病负担重(0.9±1.0和0.3±0.7;p<0.001)。RA患者中女性比例更高(82.9%比60.2%,p<0.001)。预后都包括:手术、轻微或重大的并发症、输血、需要康复或高级护理。

结果:

RA组平均住院时间(LOS)更长。RA和OA组30天死亡率没有统计学差异。RA组更可能会有急性术后贫血、输血并需要更多高级护理。RA和OA组之间的手术相关率,轻微并发症和主要并发症都没有统计学差异。

讨论和结论:通过对大医院的回顾性研究,williamhill asia 发现对健康和年轻的患者,双侧BTKA对RA患者是安全的。

原始出处

Lazaros A. Poultsides, Stavros G. Memtsoudis, Huong Do, Thomas P. Sculco, Mark P. Figgie.Rheumatoid Arthritis Does Not Increase Perioperative Complications Following Same-day Bilateral TKA.AAOS Mar 13, 2014

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
    2014-07-26 丁鹏鹏
  2. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
    2015-02-03 yinhl1978
  5. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
    2015-01-15 zywlvao
  6. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
    2014-03-13 wangbingxhy
  7. [GetPortalCommentsPageByObjectIdResponse(id=1757600, encodeId=cae21e5760040, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Jul 26 07:12:00 CST 2014, time=2014-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1642870, encodeId=d2da16428e032, content=<a href='/topic/show?id=1e19168181' target=_blank style='color:#2F92EE;'>#AAOS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1681, encryptionId=1e19168181, topicName=AAOS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c11e23034343, createdName=ms1260584454294838, createdTime=Sun Sep 21 03:12:00 CST 2014, time=2014-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053712, encodeId=82472053e12ff, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Tue Nov 04 03:12:00 CST 2014, time=2014-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2071191, encodeId=665520e11915e, content=<a href='/topic/show?id=ab241680a3' target=_blank style='color:#2F92EE;'>#AAO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1680, encryptionId=ab241680a3, topicName=AAO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Feb 03 09:12:00 CST 2015, time=2015-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1709103, encodeId=c0a61e091039a, content=<a href='/topic/show?id=cd013896021' target=_blank style='color:#2F92EE;'>#同期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38960, encryptionId=cd013896021, topicName=同期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8dd731593408, createdName=zywlvao, createdTime=Thu Jan 15 18:12:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1522368, encodeId=3287152236819, content=<a href='/topic/show?id=46223e39897' target=_blank style='color:#2F92EE;'>#双侧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37398, encryptionId=46223e39897, topicName=双侧)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=741b11453403, createdName=wangbingxhy, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526980, encodeId=cdac152698028, content=<a href='/topic/show?id=b0521e501d3' target=_blank style='color:#2F92EE;'>#TKA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17501, encryptionId=b0521e501d3, topicName=TKA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f6711785285, createdName=liuhuangbo, createdTime=Thu Mar 13 00:12:00 CST 2014, time=2014-03-13, status=1, ipAttribution=)]
    2014-03-13 liuhuangbo

相关威廉亚洲官网

ACR 2012:TNF抑制剂似乎不增加淋巴瘤风险

  根据发表于2012年美国风湿病学会年会( ACR 2012)的大型研究,对于类风湿性关节炎(RA)患者,使用肿瘤坏死因子(TNF)抑制剂治疗,与淋巴瘤风险增加并无关联。      英国曼彻斯特大学、英国流行病学关节炎研究Mercer博士表示,在有RA的背景风险下,并无证据显示使用抗TNF治疗会增加淋巴瘤风险,但需要后续追踪,以确认是否会随时间而有所变化。      这次的研究

ACR 2013:女性长期喝碳酸饮料或患增类风湿性关节炎风险

  圣迭戈——护士健康研究(NHS)与NHSⅡ汇总分析的结果显示,每天喝甜的碳酸饮料的女性罹患血清阳性类风湿性关节炎的风险大大增加。  在NHS的190万人-年和NHSⅡ的150万人-年的随访中,分别发生了563例确诊新发血清阳性类风湿性关节炎和320例血清阳性类风湿性关节炎。这两项研究共招募了238,131名定期填写饮食频率问卷的美国女性注册护士。  布里格姆妇女医院的Yang Hu医生在美国风

Arthritis Rheum:类风湿关节炎患者牙周炎高发

    一项对类风湿性关节炎(RA)患者口腔微生物群的分析研究显示,新发RA成人患者中至重度牙周炎患病率高达75%。该结果发表在10月份出版的《关节炎与风湿病》杂志(Arthritis and Rheumatism)上。   长期以来RA与口腔微生物及牙周疾病的相关性一直引起临床关注,但未见有关RA患者龈下菌群的数据报告。为此,纽约大学关节病医院关节炎诊室主任Jo

HealthDaily:女性吸烟易患类风湿性关节炎

  一项新的研究显示,吸烟女性和曾吸烟女性都易患类风湿性关节炎,而吸烟量的多少、烟龄长短都会影响类风湿性关节炎的发病概率。类风湿性关节炎会造成关节发炎,导致关节肿胀、僵硬、疼痛,且关节功能也会大受限制。风湿性关节炎不仅会影响关节,还会对身体其他部位造成伤害。   瑞典卡罗林斯卡医学院的研究人员对3.4万名女性的健康资料进行了分析,这些女性的年龄介于54岁到89岁,其中有219人患了类风湿性关节炎

NEJM:生物制剂与常规治疗急性类风湿性关节炎的效果相似

很少有盲法试验对使用缓解疾病的抗风湿性药物常规治疗与生物制剂治疗经甲氨喋呤治疗仍存在活动性疾病的类风湿性关节炎患者的疗效进行比较,而上述病情在类风湿性关节炎治疗中较为常见。James R. O'Dell博士等人对此进行了深入研究,他们发现,对于经甲氨喋呤治疗仍存在活动性疾病的类风湿性关节炎患者的临床获益而言,三种缓解疾病的抗风湿性药物(甲氨喋呤、柳氮磺吡啶、以及羟氯喹)联合治疗或依那西普加甲氨喋呤

辉瑞Xelganz获多国批准用于类风湿性关节炎(RA)

辉瑞(Pfizer)今日宣布,Xelganz(tofacitinib citrate)获多个国家批准,用于对现有疗法反应不足的类风湿性关节炎(RA)患者的治疗。其中,瑞士是欧洲首个获批准入的国家,瑞士医药管理局(Swissmedic)批准以5mg和10mg剂量Xelganz每日2次(BID)作为单药或与一种疾病修饰非生物抗风湿剂(DMARD,包